GSK BEconneCTD-ILD France
com.medable.gsk221672.patient.fr
1+
installs · ≈1
—
0 ratings
2024-11-21
first release
2024-11-21
last update
Description
This app is for registered study participants of GSK BEconneCTD-ILD France study
This app has been created exclusively for participants in the medical study for GSK BEconneCTD-ILD 221672 France. It contains Televisit functionality and allows participants to complete questionnaires.
A Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of belimumab adminstered subcutaneously in adults with interstitial lung disease (ILD) associated with connected tissue disease (CTD).
What's new
Initial release
Details
| Version | 5.4.800.3-prod |
|---|---|
| Minimum Android version | 8.0 |
| Reviews | 0 |
| Available in | American Samoa, Bulgaria, St. Barthélemy, France, French Guiana, Guadeloupe, Guam, St. Martin, Marshall Islands, Northern Mariana Islands, Martinique, New Caledonia and 9 more |
| Developer contacts | on the Business plan |
| Collected | 2026-11-14 |
This data in the API
The full record in JSON costs 1 token.
curl -H "X-API-Key: YOUR_KEY" \ "https://apkapi.com/api/v1/app?id=com.medable.gsk221672.patient.fr"
